Skip to main content

Teresa A. York, MD

Academic Title:

Assistant Professor

Primary Appointment:

Pediatrics

Administrative Title:

Interim Division Head, Hematology/Oncology-Peds

Location:

UMMC, North Hospital, N5E16 Upper Chesapeake Medical Center Lutherville Physicians Office

Phone (Primary):

(410) 328-2808

Phone (Secondary):

(410) 328-3068

Fax:

(410) 328-0571

Education and Training

M.D. - West Virginia University School of Medicine
Residency -  West Virginia University Children’s Hospital
Fellowship - Pediatric Hematology/Oncology at Medical University of South Carolina

Biosketch

B.A. - Biology, West Virginia University, 1989-93
M.D. - Medicine, West Virginia University School of Medicine, 1993-97
Pediatrics - West Virginia University Children’s Hospital, 1997-2000
Ped Hem/ Onc - Medical University of South Carolina, 2000-2003

I am currently directly involved in offering our pediatric hematology/oncology patients the most effective treatments for their disease. I have been an attending physician at the University of Maryland School of Medicine for approximately 12 years.  I am honored to participate as the principal investigator for our institution and offer cooperative group studies to our pediatric oncology patients while minimizing pain and suffering for our patients, families and caregivers.

My involvement as the principal investigator in these studies is to assist with the development and submission of these studies to the Institutional Review Board process at the University of Maryland School of Medicine. I will also help identify individuals to participate in clinical research studies and assist in explaining to patients and families what participation in these studies entail as part of the informed consent process.  I will also accept responsibility for being directly available for questions or concerns as pertains to these studies for patients, families and caregivers.  I am also directly involved in the implementation of all of the services involved in care of these patients in addition to monitoring for patient safety and proper schedule, dosing, toxicity monitoring etc as pertains to these patients’ receiving care at our institution.  I look forward to participating in these studies and we are committed as a team for our success so that we as healthcare professionals can obtain more knowledge and information on how to best help patients, families and caregivers cope with their illness and the pain and suffering it brings.

Research/Clinical Keywords

Leukemia, lymphoma, solid tumors, blood disorders and cancer survivorship

Highlighted Publications

Mudry,R.,Fortney J., York T., Hall B.,Gibson L.: Stromal Cells Regulate Survival of B-Lineage Leukemic Cells During Chemotherapy. Blood, 1 Sept. 2000, 96(5): 1926-32

Leclerc GJ, York TA, Hsieh-Kinser T, Barredo JC: Molecular Basis for Decreased Folylpoly-gamma-glutamate Synthetase Expression in a Methotrexate Resistant CCRF-CEM mutant cell line. Leuk Res. 2007 Mar; 31 (3):293-9. Epub 2006 Aug 1

Zhao F, Gojo I, York T, Ning Y, Baer M:Diagnosis of biphenotypic acute leukemia: a paradigmatic approach. Int J Clin Exp Pathol 2010;3(1):75-86

Awards and Affiliations

Grants and Contracts

Previous Positions

Professional Memberships

×